TY - JOUR
T1 - The breast-thyroid cancer link
T2 - A systematic review and meta-analysis
AU - Nielsen, Sarah M.
AU - White, Michael G.
AU - Hong, Susan
AU - Aschebrook-Kilfoy, Briseis
AU - Kaplan, Edwin L.
AU - Angelos, Peter
AU - Kulkarni, Swati A.
AU - Olopade, Olufunmilayo I.
AU - Grogan, Raymon H.
N1 - Funding Information:
This work was funded by the Ralph and Marion Falk Medical Research Trust and the American Cancer Society (to O.I. Olopade). R.H. Grogan was supported by Award Number K12CA139160 from the National Cancer Institute.
Publisher Copyright:
© 2016 American Association for Cancer Research.
PY - 2016/2
Y1 - 2016/2
N2 - Rates of thyroid cancer in women with a history of breast cancer are higher than expected. Similarly, rates of breast cancer in those with a history of thyroid cancer are increased. Explanations for these associations include detection bias, shared hormonal risk factors, treatment effect, and genetic susceptibility. With increasing numbers of breast and thyroid cancer survivors, clinicians should be particularly cognizant of this association. Here, we perform a systematic review and metaanalysis of the literature utilizing PubMed and Scopus search engines to identify all publications studying the incidence of breast cancer as a secondary malignancy following a diagnosis of thyroid cancer or thyroid cancer following a diagnosis of breast cancer. This demonstrated an increased risk of thyroid cancer as a secondary malignancy following breast cancer [OR = 1.55; 95% confidence interval (CI), 1.44-1.67] and an increased risk of breast cancer as a secondary malignancy following thyroid cancer (OR = 1.18; 95% CI, 1.09-1.26). There is a clear increase in the odds of developing either thyroid or breast cancer as a secondary malignancy after diagnosis with the other. Here, we review this association and current hypothesis as to the cause of this correlation.
AB - Rates of thyroid cancer in women with a history of breast cancer are higher than expected. Similarly, rates of breast cancer in those with a history of thyroid cancer are increased. Explanations for these associations include detection bias, shared hormonal risk factors, treatment effect, and genetic susceptibility. With increasing numbers of breast and thyroid cancer survivors, clinicians should be particularly cognizant of this association. Here, we perform a systematic review and metaanalysis of the literature utilizing PubMed and Scopus search engines to identify all publications studying the incidence of breast cancer as a secondary malignancy following a diagnosis of thyroid cancer or thyroid cancer following a diagnosis of breast cancer. This demonstrated an increased risk of thyroid cancer as a secondary malignancy following breast cancer [OR = 1.55; 95% confidence interval (CI), 1.44-1.67] and an increased risk of breast cancer as a secondary malignancy following thyroid cancer (OR = 1.18; 95% CI, 1.09-1.26). There is a clear increase in the odds of developing either thyroid or breast cancer as a secondary malignancy after diagnosis with the other. Here, we review this association and current hypothesis as to the cause of this correlation.
UR - http://www.scopus.com/inward/record.url?scp=84957806067&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84957806067&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-15-0833
DO - 10.1158/1055-9965.EPI-15-0833
M3 - Review article
C2 - 26908594
AN - SCOPUS:84957806067
SN - 1055-9965
VL - 25
SP - 231
EP - 238
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 2
ER -